美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corgi U.S. Biotech 2x Daily ETF

38.92

-1.3372-3.32%

成交量：912

成交额：3.55万

市值：77.84万

市盈率：- -

高：38.92

开：38.92

低：38.92

收：40.26

52周最高：42.22

52周最低：25.26

股本：2.00万

流通股本：2.00万

量比：4.60

换手率：4.56%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

美银证券：中国CXO行业受惠生物科技融资强劲上调药明康德等目标价

重塑全球药企版图！阿斯利康拟洽购百时美施贵宝，或缔造史上最大医药并购案

重塑全球药企版图！阿斯利康(AZN.US)拟洽购百时美施贵宝(BMY.US)，或缔造史上最大医药并购案

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/XBIX"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","market":"US","secType":"STK","nameCN":"Corgi U.S. Biotech 2x Daily ETF","latestPrice":38.92,"timestamp":1787587969133,"preClose":40.2572,"halted":0,"volume":912,"delay":0,"changeRate":-0.03321641842949822,"floatShares":20000,"shares":20000,"eps":0,"marketStatus":"交易中","change":-1.3372,"latestTime":"08-24 12:19:01 EDT","open":38.9199,"high":38.92,"low":38.9199,"amount":35494.554816,"amplitude":0.000002,"askPrice":39.69,"askSize":200,"bidPrice":39.57,"bidSize":200,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":40.2572,"nav":39.14,"aum":782800,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":40.8,"preClose":40.2572,"latestTime":"19:36 EDT","volume":3,"amount":120.1544,"timestamp":1787355411675,"change":0.5428,"changeRate":0.013483,"amplitude":0},"volumeRatio":4.600341},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","floatShares":20000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.600341,"shares":20000,"dividePrice":0,"high":38.92,"amplitude":0.000002,"preClose":40.2572,"low":38.9199,"week52Low":25.2639,"pbRate":"--","week52High":42.2188,"institutionHeld":0,"latestPrice":38.92,"eps":0,"divideRate":0,"volume":912,"delay":0,"ttmEps":0,"open":38.9199,"prevYearClose":25.42,"prevWeekClose":40.2572,"prevMonthClose":32.1639,"prevQuarterClose":37.7974,"fiveDayClose":37.5332,"twentyDayClose":33.9733},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBIX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBIX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBIX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659138517","title":"美银证券：中国CXO行业受惠生物科技融资强劲 上调药明康德等目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2659138517","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659138517?lang=zh_cn&edition=fundamental","pubTime":"2026-08-13 12:41","pubTimestamp":1786596060,"startTime":"0","endTime":"0","summary":"模拟交易客户端美银证券发布研报称，受惠上半年全球及中国生物科技一级市场融资表现强劲，加上创新药对外授权交易持续活跃，预期研发活动将进一步加快，中国CRO/CDMO企业可望受惠。该行上调药明康德H股目标价由204.3港元至242港元，药明康德A股目标价由177.8元人民币至210.5元人民币，维持“买入”评级，因其增长能见度清晰。该行并上调药明康德2029至2035年收入估算介乎3%至7%，经调整纯利预测亦上调介乎3%至7%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2026-08-13/doc-inincxku3329313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LFSC","PSCH","02359","IBRN","PSIL","XBIX","MEDI","FHLC","SMCO","SURI","APXH","WX","161027","CXO","IDNA","BMED","603259","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656346866","title":"重塑全球药企版图！阿斯利康拟洽购百时美施贵宝，或缔造史上最大医药并购案","url":"https://stock-news.laohu8.com/highlight/detail?id=2656346866","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656346866?lang=zh_cn&edition=fundamental","pubTime":"2026-08-03 07:30","pubTimestamp":1785713456,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据知情人士透露，阿斯利康已就收购百时美施贵宝展开探讨，这桩超级交易若达成，将缔造全球规模最大的制药企业之一。阿斯利康市值超过百时美施贵宝百时美施贵宝正为其部分最核心产品面临专利保护到期做准备，包括抗凝药艾乐妥与抗癌药欧狄沃。两款产品合计约占百时美施贵宝销售额的一半。上周，百时美施贵宝公布季度销售额 130 亿美元，创历史最高。阿斯利康目前是伦敦证券交易所市值第二大的公司。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"重塑全球药企版图！阿斯利康拟洽购百时美施贵宝，或缔造史上最大医药并购案","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2242652126.USD","LU2237443465.HKD","XPH","LU1323610961.USD","IE0009355771.USD","LU0456855351.SGD","RXD","IEHS","IE00B5TLWC47.USD","BK4559","LU2237443549.SGD","LU1291159041.SGD","LU2272731600.USD","PILL","LU2456880835.USD","LU0432979614.USD","LU2237443622.USD","LU1093756325.SGD","BK4534","FTXH","JHMH","LU2237443978.SGD","BK4581","SYNB","LU1718418525.SGD","LU0061475181.USD","LU1032466523.USD","IE00B3T34201.USD","IE00BJT1NW94.SGD","XBIX","LU2473716301.USD","PPH","IE00BSNM7G36.USD","LU1992135472.HKD","LU2360032135.SGD","FHLC","LU2125154778.USD","AZN","LU0096364046.USD","RXL","LU1585245621.USD","MEDI","LU0029864427.USD","BMY","AZNH","IE00BFTCPJ56.SGD","IHE","LU2237443382.USD","CURE","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656468693","title":"重塑全球药企版图！阿斯利康(AZN.US)拟洽购百时美施贵宝(BMY.US)，或缔造史上最大医药并购案","url":"https://stock-news.laohu8.com/highlight/detail?id=2656468693","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656468693?lang=zh_cn&edition=fundamental","pubTime":"2026-08-03 07:25","pubTimestamp":1785713101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2456880835.USD","FXH","LU1670710661.SGD","FTXH","LU1989771016.USD","AZN","XPH","BK4581","IE00BFTCPJ56.SGD","PPH","LU0225771236.USD","BK4534","MEDI","IE00B3T34201.USD","LU1267930573.SGD","LU1074936037.SGD","LU0237698245.USD","LU1032466523.USD","BK4588","LU0456855351.SGD","LU2272731782.SGD","RXD","RXL","FHLC","IEHS","CURE","JHMH","LU0029864427.USD","LU0985481810.HKD","SYNB","LU1868836914.USD","IHE","IE00B5TLWC47.USD","LU2089984988.USD","BMY","LU2125154935.USD","IE00BFXG1179.USD","PILL","LU0096364046.USD","LU0306807586.USD","LU0058720904.USD","LU1868837136.USD","XBIX","IE00BSNM7G36.USD","AZNH","LU1670711123.USD","IE0009355771.USD","IE0002141913.USD","LU2596442595.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XBIX\",params:#limit:6,delay:false,,,undefined,":[]}}